Pharma News

Pharma Courses 
PAGE Admission

Get the latest news from world and India’s leading pharmaceutical companies Pharma Industry, pharmaceutical marketing, generic drugs, and Complete news for Pharmacy and Life Sciences professionals.

  • Torrent Pharmaceuticals earn 100 percent equity stake in Zyg Pharma Pvt Ltd, a company engaged in manufacturing various dermatological formulations like creams, ointments, gels, lotions, solutions, for undisclosed price.

  • CyMedica Orthopedics, Inc.,  has commercially launched the CyMedica QB1 System for the treatment of quadriceps muscle atrophy. The CyMedica QB1 System has introduced at the Arthroscopy Association of North American Arthroscopic Society for Sports Medicine (AANA) annual meeting in Los Angeles recently.

  • Biocon, a leading innovation-led bio-pharmaceutical company, has announced satisfactory financial performance during the fourth quarter ended March 2014. Its consolidated net profit, after exceptional income of Rs. 105 crore on account of sale of Syngene shares, increased by 78.2 per cent to Rs. 201.54 crore from Rs. 113.08 crore in the corresponding period of last year. Operating profit jumped 4.7 percent year-on-year to Rs 202 crore for the quarter ended March 2015 from Rs 193 crore in the same quarter last year.Profit before tax and exceptional income also improved by only 4 per cent to Rs. 143.54 crore from Rs. 138.06 crore. EPS moved up to Rs. 10.08 from Rs. 5.76 crore.  Its consolidated net sales increased by 14.9 per cent to Rs. 830.38 crore during the fourth quarter from Rs. 722.59 crore in the same period of last year. Its pharma sales increased by 10.8 per cent to Rs. 594.91 crore from Rs. 536.77 crore and that of contract research & manufacturing services improved by 27.7 per cent to Rs. 248.92 crore from Rs. 194.90 crore.

  • In Maharashtra doctors demanding for simplification of F-Form of Pre-Conception and Pre-Natal Diagnostic Techniques (PCPNDT) Act. Filling-up of F-Form a tedious and lengthy job. F-Form is an important document for maintaining the record in case of prenatal diagnostic test/procedure by genetic clinic/ultrasound clinic and imaging centre.

  • Bosch Packaging Technology, one of the leading suppliers introduce the new granulation unit, GranuLean at Achema 2015 to be held in Germany from June 15 to 19, 2015. It ranges from filling, processing, and packaging technology for piece goods and bulk items in the food, pharmaceutical, and confectionery sectors as well as for health and hygiene products.

  • Researchers studying the commonly used pain reliever acetaminophen or paracetamol have found that it has a previously unknown side effect: it blunts positive emotions. In the study, participants who took acetaminophen reported less strong emotions when they saw both very pleasant and very disturbing photos, when compared to those who took placebos.

  • Ella Foundation of Bharat Biotech has successfully tested a preliminary vaccine for Ebola on mice. Ella Foundation has been trying to discover a suitable vaccine to check the deadly viral disease that shook the world recently. Vaccine from adenovirus and glycoprotein was tested on mice and the good results were found to be  for developing a full-fledged vaccine. Adenoviruses are accountable for respiratory infections, gastroenteritis, cystitis, and primary pneumonia in humans, and are used as a clear target to understand the human immunity characteristics in laboratory. However, the efficacy of the vaccine will be evaluated by the results seen in human trials.

    Ebola, previously known as Ebola hemorrhagic fever, is a rare and deadly disease caused by infection with one of the Ebola virus strain. Ebola is a multi-organ infecting disease. The virus could spread fast through human touch. Particularly India needs to be vigilant in containing this disease. Having understood the gravity of the situation across the world due to this disease the efforts of Bharat Biotech and its foundation are hailed all over.  It has not yet hit India. The worst hit part of the world is Africa.

    Other major companies that are working to provide a fool proof vaccine solution to Ebola in the world are GlaxoSmitKline, Johnson & Johnson, Merck and Novavax. All these companies combined have invested an amount of approximately 500 million towards research and development of this vaccine.

    << Pharma News


    Subscribe to PharmaTutor News Alerts by Email >>

Subscribe to Pharma News